Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.

Autor: Signoriello E; Second Division of Neurology, University of Campania Luigi Vanvitelli - Naples, Italy., Signori A; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy., Lus G; Second Division of Neurology, University of Campania Luigi Vanvitelli - Naples, Italy., Romano G; Second Division of Neurology, University of Campania Luigi Vanvitelli - Naples, Italy., Marfia GA; Multiple Sclerosis Clinical and Research Unit, Department of System Medicine, Tor Vergata University, Rome, Italy., Landi D; Multiple Sclerosis Clinical and Research Unit, Department of System Medicine, Tor Vergata University, Rome, Italy., Napoli F; Multiple Sclerosis Clinical and Research Unit, Department of System Medicine, Tor Vergata University, Rome, Italy., D' Amico E; Department of Medical and Surgical Sciences, University of Foggia, Italy., Zanghí A; Department of Medical and Surgical Sciences, University of Foggia, Italy., Di Filippo PS; Department of Medical and Surgical Sciences, University of Foggia, Italy., Caliendo D; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy., Carotenuto A; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy., Spiezia AL; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy., Fantozzi R; IRCCS Neuromed, 86077 Pozzilli, Italy., Centonze D; IRCCS Neuromed, 86077 Pozzilli, Italy; Department of System Medicine, Tor Vergata University, 00133 Rome, Italy., Lucchini M; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore, CERSM, Roma, Italy., Mirabella M; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore, CERSM, Roma, Italy., Cocco E; Multiple Sclerosis Centre, ASL Cagliari, Cagliari, Italy; Dpt of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Frau J; Multiple Sclerosis Centre, ASL Cagliari, Cagliari, Italy., Maniscalco GT; MS and Neuroimmunology Center, A Cardarelli Hospital,Naples, Italy., Di Battista ME; MS and Neuroimmunology Center, A Cardarelli Hospital,Naples, Italy., Foschi M; Department of Neuroscience, Multiple Sclerosis Center - Neurology Unit, S.Mariadelle Croci Hospital, AUSL Romagna, Ravenna, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Surcinelli A; Department of Neuroscience, Multiple Sclerosis Center - Neurology Unit, S.Mariadelle Croci Hospital, AUSL Romagna, Ravenna, Italy., Bonavita S; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, I Clinic of Neurology, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Abbadessa G; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, I Clinic of Neurology, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Pasquali L; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Di Gregorio M; Neurology Unit, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Largo Città di Ippocrate, 84100, Salerno, Italy., Ferrò MT; Neuroimmunology and Multiple Sclerosis Center, A.S.S.T. of Crema, Italy., Sormani MP; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Schiavetti I; Department of Health Sciences, Section of Biostatistics, University of Genoa, Genoa, Italy. Electronic address: irene.schiavetti@unige.it.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jul; Vol. 87, pp. 105594. Date of Electronic Publication: 2024 Apr 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Autor: Moccia M; Multiple Sclerosis Unit, Policlinico Federico II University Hospital of Naples, Naples, Italy., Santoni L, Vaccari I, Affinito G, Caliendo D, Rubba F, Lanzillo R, Triassi M, Brescia Morra V, Palladino R

Publikováno v: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2024 Feb; Vol. 28 (4), pp. 1241.

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis.

Autor: Caliendo D, Puca A; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy., Lavorgna L; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Carotenuto A; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy., Petracca M; Department of Human Neurosciences, Sapienza University, Rome, Italy., Lanzillo R, Brescia Morra V; Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy; Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy., Moccia M; Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, Naples, Italy.

Publikováno v: Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2023 Sep 16; Vol. 9 (3), pp. 20552173231202123. Date of Electronic Publication: 2023 Sep 16 (Print Publication: 2023).